A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.

The medication failed a routine dissolution test, meaning it could lose its effectiveness. 

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

Football players whose heads are repeatedly struck but suffer no concussions have white-matter abnormalities similar to those sustained by their concussed peers. 

“For patients with cardiovascular disease, abortion access is a critical part of their comprehensive cardiovascular and reproductive care,” according to the three authors of a new commentary piece in JAMA Cardiology.

A federal judge has dismissed a class-action lawsuit filed by patients over a data breach at a four-location radiology practice and its countrywide parent company.